Trial
NCT00096369
Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Texas Southwestern Medical Center
Collaborators
National Cancer Institute (NCI)
Condition
Breast Cancer
Intervention
tamoxifen citrate
Why stopped
accrual goal not met
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-01-24